Transmedics Group Inc
NASDAQ:TMDX

Watchlist Manager
Transmedics Group Inc Logo
Transmedics Group Inc
NASDAQ:TMDX
Watchlist
Price: 90.45 USD -1.7% Market Closed
Market Cap: 3.1B USD

Intrinsic Value

The intrinsic value of one TMDX stock under the Base Case scenario is 41.02 USD. Compared to the current market price of 90.45 USD, Transmedics Group Inc is Overvalued by 55%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

TMDX Intrinsic Value
41.02 USD
Overvaluation 55%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Transmedics Group Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
TMDX
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for TMDX cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Transmedics Group Inc
NASDAQ:TMDX
US
Health Care
Market Cap
3B USD
IPO
May 2, 2019
US
Health Care
Market Cap
3B USD
IPO
May 2, 2019
Price
$false
EPS
$false
AI Assistant
AI Assistant
Ask me anything about Transmedics Group Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Transmedics Group Inc

Current Assets 497.2m
Cash & Short-Term Investments 336.7m
Receivables 97.7m
Other Current Assets 62.8m
Non-Current Assets 306.9m
PP&E 292.5m
Intangibles 13.7m
Other Non-Current Assets 708k
Efficiency

Free Cash Flow Analysis
Transmedics Group Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Transmedics Group Inc

Revenue
441.5m USD
Cost of Revenue
-179.5m USD
Gross Profit
262.1m USD
Operating Expenses
-224.6m USD
Operating Income
37.5m USD
Other Expenses
-2m USD
Net Income
35.5m USD
Fundamental Scores

TMDX Profitability Score
Profitability Due Diligence

Transmedics Group Inc's profitability score is 43/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Positive Gross Profit
Exceptional 1-Year Revenue Growth
ROE is Increasing
43/100
Profitability
Score

Transmedics Group Inc's profitability score is 43/100. The higher the profitability score, the more profitable the company is.

TMDX Solvency Score
Solvency Due Diligence

Transmedics Group Inc's solvency score is 46/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Positive Net Debt
Average Altman Z-Score
46/100
Solvency
Score

Transmedics Group Inc's solvency score is 46/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

TMDX Price Targets Summary
Transmedics Group Inc

Wall Street analysts forecast TMDX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TMDX is 117.94 USD with a low forecast of 80.8 USD and a high forecast of 187.95 USD.

Lowest
Price Target
80.8 USD
11% Downside
Average
Price Target
117.94 USD
30% Upside
Highest
Price Target
187.95 USD
108% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Transmedics Group Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for TMDX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

TMDX Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one TMDX stock?

The intrinsic value of one TMDX stock under the Base Case scenario is 41.02 USD.

Is TMDX stock undervalued or overvalued?

Compared to the current market price of 90.45 USD, Transmedics Group Inc is Overvalued by 55%.

Back to Top